Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer

被引：1
|
作者：
Sousa, Catarina C. [1 ]
Pinto, Josue [1 ]
Martins, Natalia [1 ,2 ,3 ]
Teixeira, Sofia [4 ]
Magalhaes, Adriana [1 ]
Fernandes, Gabriela [1 ,2 ,3 ]
Hespanhol, Venceslau [1 ,2 ,3 ]
Queiroga, Henrique [1 ,2 ,3 ]
Bastos, Helder Novais [1 ,2 ,3 ]
机构：
[1] Univ Hosp Ctr Sao Joao, Dept Pulmonol, Porto, Portugal
[2] Univ Porto, Fac Med, Porto, Portugal
[3] Univ Porto, Inst Res & Innovat Hlth, Porto, Portugal
[4] Univ Minho, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
D O I：
10.1183/13993003.congress-2019.PA4684
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA4684
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Management of Brain Metastases in Patients with EGFR Mutated Advanced Non-Small Cell Lung Cancer
    O'Rourke, Noelle
    Gray, Christine M. N.
    Coyte, Aishah
    Featherstone, Carolyn
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S526 - S526
  • [42] Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer TP53 mutations
    Fukuda, Koji
    Takeuchi, Shinji
    Arai, Sachiko
    Nanjo, Shigeki
    Sato, Shigeki
    Kotani, Hiroshi
    Kita, Kenji
    Nishiyama, Akihiro
    Sakaguchi, Hiroyuki
    Ohtsubo, Koshiro
    Yano, Seiji
    CELL REPORTS MEDICINE, 2024, 5 (06)
  • [43] Epithelial-mesenchymal transition status is a remarkable biomarker for the combination treatment with avutometinib and defactinib in KRAS-mutated non-small cell lung cancer
    Yoshimura, Akihiro
    Horinaka, Mano
    Yaoi, Takeshi
    Ono, Hisako
    Itoh, Kyoko
    Yamada, Tadaaki
    Takayama, Koichi
    Sakai, Toshiyuki
    BRITISH JOURNAL OF CANCER, 2024, 131 (02) : 361 - 371
  • [44] MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer
    Fanini, Francesca
    Bandini, Erika
    Plousiou, Meropi
    Carloni, Silvia
    Wise, Petra
    Neviani, Paolo
    Murtadha, Mariam
    Foca, Flavia
    Fabbri, Francesco
    Vannini, Ivan
    Fabbri, Muller
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [45] The Diverse Analysis Identifies Mutated KRAS Associated With Radioresistance in Non-Small Cell Lung Cancer
    Zhu, Dao Qi
    Liu, Ying
    Yu, Zhi Jian
    Zhang, Ru Hua
    Li, Ai Wu
    Gong, Feng Ying
    Wang, Wei
    Xiao, Wei
    Fan, Qin
    WORLD JOURNAL OF ONCOLOGY, 2022, 13 (02) : 84 - 95
  • [46] MicroRNAs: a new tool in the complex biology of KRAS mutated non-small cell lung cancer?
    Renaud, Stephane
    Seitlinger, Joseph
    Massard, Gilbert
    JOURNAL OF THORACIC DISEASE, 2017, 9 (04) : 957 - 960
  • [47] Targeting KRAS in Non-Small Cell Lung Cancer
    Corral de la Fuente, Elena
    Olmedo Garcia, Maria Eugenia
    Gomez Rueda, Ana
    Lage, Yolanda
    Garrido, Pilar
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [48] KRAS-mutated non-squamous non-small cell lung cancer. Comprehensive analysis of co-mutations and PDL1-expression
    Cristobal Redondo, V.
    Pedrero Castillo, V.
    Roca, R.
    Ortuno, S.
    Martinez-Banaclocha, N.
    Alenda Gonzalez, C.
    Aranda Lopez, I.
    VIRCHOWS ARCHIV, 2024, 485 : S131 - S131
  • [49] Efficacy and safety outcomes in patients receiving sotorasib for advanced KRAS G12C-mutated non-small cell lung cancer
    Milner-Watts, Charlotte
    O'Sullivan, Hazel
    Stewart, James
    Idaikkadar, Praveena
    Tokaca, Nadza
    Davidson, Michael
    Yousaf, Nadia
    Bhosle, Jaishree
    Popat, Sanjay
    O'Brien, Mary
    Minchom, Anna
    LUNG CANCER, 2023, 178 : S31 - S32
  • [50] Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC).
    Liu, Stephen, V
    Vanderwalde, Ari M.
    Mamdani, Hirva
    Raez, Luis E.
    Baca, Yasmine
    Xiu, Joanne
    Korn, Wolfgang Michael
    Nagasaka, Misako
    Pai, Sachin Gopalkrishna
    Socinski, Mark A.
    Nieva, Jorge J.
    Kim, Chul
    Wozniak, Antoinette J.
    Ikpeazu, Chukwuemeka
    Lopes, Gilberto
    Spira, Alexander, I
    Judd, Julia
    Kim, Edward S.
    Borghaei, Hossein
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345